Ignite Creation Date:
2025-12-25 @ 12:27 AM
Ignite Modification Date:
2025-12-25 @ 10:33 PM
Study NCT ID:
NCT05585567
Status:
UNKNOWN
Last Update Posted:
2022-11-07
First Post:
2022-10-13
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5
Sponsor:
Livzon Pharmaceutical Group Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2022-10-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-09-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-10-13
First Submit QC Date:
None
Study First Post Date:
2022-10-19
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-11-03
Last Update Post Date:
2022-11-07
Last Update Post Date Type:
ACTUAL